University of Tennessee Medical Center Office of Clinical Trials ( Site 0046)

Knoxville, Tennessee 37920

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
University of Tennessee Medical Center Office of Clinical Trials ( Site 0046)
mi
from
Knoxville, TN
Click here to add this to my saved trials